Authors: IVESON T EGGLETON SPH HICKISH T CUNNINGHAM D MAUGHAN T HARPER P

Citation: T. Iveson et al., IRINOTECAN (CPT-11) IN 5-FU PRETREATED ADVANCED COLORECTAL-CANCER - RESULTS IN 174 EXPANDED ACCESS PATIENTS, Annals of oncology, 9, 1998, pp. 174-174

Authors: JUDSON I MAUGHAN T BEALE P PRIMROSE J HOSKIN P HANWELL J BERRY C WALKERS M SUTCLIFFE F

Citation: I. Judson et al., EFFECTS OF IMPAIRED RENAL-FUNCTION ON THE PHARMACOKINETICS OF RALTITREXED (TOMUDEX ZD1694), British Journal of Cancer, 78(9), 1998, pp. 1188-1193

Authors: HALE J COHEN D MAUGHAN T

Citation: J. Hale et al., ECONOMICS OF THE MRC COLORECTAL WORKING PARTY CR06 TRIAL, European journal of cancer, 33, 1997, pp. 13-13

Authors: OSTERBORG A DYER MJS BUNJES D PANGALIS GA BASTION Y CATOVSKY D MELLSTEDT H RANKIN E TSEKOURAS C PANGALIS GA CAVALLI F SESSA C HUHN D MARCUS R MAUGHAN T POYNTON C NISSEN N CARNEY D BRITTINGER G UPPENKAMP M ELONEN E TEERENHOVI L",ENGERT,"WILLEMZE R KLUINNELEMANS J THOMAS J EPENETOS AA NETHERSELL A DYER M CATOVSKY D DICATO M BASTION Y COIFFIER B RANADA JMF CROWTHER D WOLL P RAEMAKAERS J DEPAUW B DEGOS L",GISSELLBRECHT,"REIFFERS J MELLSTEDT H FASSAS A ANAGNOSTOPOULOS A BUNJES D JAEGER U STAHEL RA

Citation: A. Osterborg et al., PHASE-II MULTICENTER STUDY OF HUMAN CD52 ANTIBODY IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA, Journal of clinical oncology, 15(4), 1997, pp. 1567-1574

Authors: POYNTON CH MAUGHAN T JEBB S ELIA M

Citation: Ch. Poynton et al., GLYCYL L-GLUTAMINE REDUCES OUT TOXICITY IN BONE-MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 2258-2258